![JCI - Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model JCI - Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model](https://dm5migu4zj3pb.cloudfront.net/manuscripts/153000/153090/medium/JCI153090.ga.jpg)
JCI - Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
![Antibiotics | Free Full-Text | Medicinal Plants as Therapeutic Alternatives to Combat Mycobacterium tuberculosis: A Comprehensive Review Antibiotics | Free Full-Text | Medicinal Plants as Therapeutic Alternatives to Combat Mycobacterium tuberculosis: A Comprehensive Review](https://pub.mdpi-res.com/antibiotics/antibiotics-12-00541/article_deploy/html/images/antibiotics-12-00541-g001.png?1678270282)
Antibiotics | Free Full-Text | Medicinal Plants as Therapeutic Alternatives to Combat Mycobacterium tuberculosis: A Comprehensive Review
![Insights into Recurrent Tuberculosis: Relapse Versus Reinfection and Related Risk Factors | IntechOpen Insights into Recurrent Tuberculosis: Relapse Versus Reinfection and Related Risk Factors | IntechOpen](https://cdnintech.com/media/chapter/59460/1512345123/media/F1.png)
Insights into Recurrent Tuberculosis: Relapse Versus Reinfection and Related Risk Factors | IntechOpen
![Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor | Cellular & Molecular Immunology Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor | Cellular & Molecular Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41423-021-00694-9/MediaObjects/41423_2021_694_Fig1_HTML.png)
Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor | Cellular & Molecular Immunology
![John Libbey Eurotext - European Cytokine Network - Review: Reactivation of tuberculosis by tumor necrosis factor neutralization John Libbey Eurotext - European Cytokine Network - Review: Reactivation of tuberculosis by tumor necrosis factor neutralization](https://www.jle.com/e-docs/00/04/2D/D4/texte_alt_jleecn00133_gr1.jpg)
John Libbey Eurotext - European Cytokine Network - Review: Reactivation of tuberculosis by tumor necrosis factor neutralization
![Frontiers | Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells Frontiers | Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells](https://www.frontiersin.org/files/Articles/594572/fimmu-11-594572-HTML/image_m/fimmu-11-594572-g001.jpg)
Frontiers | Initiation of Post-Primary Tuberculosis of the Lungs: Exploring the Secret Role of Bone Marrow Derived Stem Cells
![The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy | Annals of Saudi Medicine The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy | Annals of Saudi Medicine](https://www.annsaudimed.net/cms/asset/9e64a833-ac8e-431f-919d-4ae5bf03b9b0/asm-5-285.jpg)
The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy | Annals of Saudi Medicine
![Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing | BMC Infectious Diseases | Full Text Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3164-z/MediaObjects/12879_2018_3164_Fig1_HTML.png)
Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing | BMC Infectious Diseases | Full Text
![Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics](https://static.hindawi.com/articles/mi/volume-2017/8909834/figures/8909834.fig.001.jpg)